Document is current
Any future updates will be listed below
-
Authors
Cao, Yuanzhao https://orcid.org/0000-0001-6406-4239
Redd, Meredith A.
Outhwaite, Jennifer E.
Mizikovsky, Dalia
Shim, Woo Jun https://orcid.org/0000-0001-9446-7821
Fang, Chen https://orcid.org/0009-0004-1148-7931
Vedelago, Courtney
Tan, Clarissa
Wu, Zhixuan
Daygon, Dara https://orcid.org/0000-0003-0805-5148
Stark, Terra
Palfreyman, Robin
Chiu, Han Sheng
Thomas, Ulrich
Dragicevic, Elena
Sng, Julian D. J. https://orcid.org/0000-0001-7837-4473
Saez, Natalie J.
Barrett, Helen L.
Dorey, Emily S. https://orcid.org/0009-0002-7906-1967
King, Glenn F. https://orcid.org/0000-0002-2308-2200
Wuethrich, Alain https://orcid.org/0000-0001-9569-0478
Trau, Matt https://orcid.org/0000-0001-5516-1280
Shah, Sonia https://orcid.org/0000-0001-5860-4526
Short, Kirsty R. https://orcid.org/0000-0003-4963-6184
Palpant, Nathan J. https://orcid.org/0000-0002-9334-8107
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 23 March 2026
First Online: 18 April 2026
Competing interests
: N.P. and G.K. are co-founders and equity holders in Infensa Bioscience, a company developing therapeutics for ischaemic heart disease, which is related to the subject matter of this study. N.S. and H.C. are employees of Infensa Bioscience. The remaining authors declare no competing interests.
